Article info
PDFOriginal article
Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease
- Correspondence to Dr Alexander C Mackinnon, University of Chicago Medical Center, 5841 S Maryland Avenue, MC 2115, Chicago, IL 60637, USA; alexander.mackinnon{at}uchospitals.edu
Citation
Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease
Publication history
- Accepted September 21, 2010
- First published November 2, 2010.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.